Literature DB >> 2317121

Measurement of joint inflammation in rheumatoid arthritis with indium-111 chloride.

R H Shmerling1, J A Parker, W D Johns, D E Trentham.   

Abstract

Studies in the collagen and rabbit models of arthritis have indicated that indium-111 chloride (111InCl3) scintigraphy objectively measures synovial inflammation. Indium-111 chloride scans, with imaging three days after 19 MBq intravenous injection, were performed on 21 patients with definite or classical rheumatoid arthritis (RA), all of whom were functional class II. Standard clinical indices of disease activity were recorded at the time of imaging by the same investigator, who was unaware of the results of joint scans. In addition, eight patients with severe osteoarthritis, four of whom were considered to need hip or knee joint replacement, were similarly scanned. In each patient 16 joints were graded as 0 to 5, based on increasing degrees of 111InCl3 uptake, by a single investigator blinded to the patient's diagnosis and clinical status. In the group with RA significant correlations were observed between individual joint uptake on scan and peripheral joints with swelling, joints reported to be painful, and joints with any abnormality on physical examination. In the group with osteoarthritis joints positive on scan correlated with the presence of pain. A total scan score (sum of individual joint scores) was calculated for each patient. In the patients with RA values ranged from 0 to 42 with a mean (SEM) of 20.7 (2.7) and correlated with the number of swollen joints and decreasing grip strength. In the group with osteoarthritis the mean total scan score (9.2 (1.5), range 3-14) was significantly lower than in the patients with RA. These data show that 111InCl3 scanning can measure joint involvement by RA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317121      PMCID: PMC1003984          DOI: 10.1136/ard.49.2.88

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Activation of rat synovium by iron.

Authors:  M de Sousa; R Dynesius-Trentham; F Mota-Garcia; M T da Silva; D E Trentham
Journal:  Arthritis Rheum       Date:  1988-05

3.  Nature of anaemia in rheumatoid arthritis. XI. Changes in iron metabolism induced by the administration of corticotrophin.

Authors:  A G Mowat; T E Hothersall; W R Aitchison
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

4.  The metabolism of transferrin-bound 111In and 59Fe in the rat.

Authors:  M R Beamish; E B Brown
Journal:  Blood       Date:  1974-05       Impact factor: 22.113

5.  Behavior of iron-, indium-, and iodine-labeled transferrin.

Authors:  S E Graber; P J Hurley; R M Heyssel; P A McIntyre
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

6.  2,000-centiGray total lymphoid irradiation for refractory rheumatoid arthritis.

Authors:  D E Trentham; J A Belli; W D Bloomer; R J Anderson; H Lane; E L Reinherz; K F Austen
Journal:  Arthritis Rheum       Date:  1987-09

7.  Indium-111 chloride scintigraphy in adult osteomyelitis.

Authors:  S E Iles; L E Ehrlich; J C Saliken; R H Martin
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

8.  Evaluation of indium-111 chloride as a radiopharmaceutical for joint imaging in a rabbit model of arthritis.

Authors:  M R Zalutsky; M de Sousa; P Venkatesan; S Shortkroff; J Zuckerman; C Sledge
Journal:  Invest Radiol       Date:  1987-09       Impact factor: 6.016

9.  Cyclosporin A treatment of refractory rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; P A Fraser; R J Anderson; J Spragg; D E Trentham; K F Austen
Journal:  Arthritis Rheum       Date:  1987-01

10.  Efficacy of low-dose methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; D A Fox; P A Fraser; D E Holdsworth; D N Glass; D E Trentham
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.